Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Otorhinolaryngology

  Free Subscription


Articles published in Head Neck

Retrieve available abstracts of 456 articles:
HTML format



Single Articles


    May 2020
  1. FOKI E, Gangl K, Kranebitter V, Niederberger-Leppin V, et al
    Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26247.
    PubMed     Abstract available


  2. LEE J, Shin IS, Kim WC, Yoon WS, et al
    Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: Meta-analysis and systematic review.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26264.
    PubMed     Abstract available


  3. NILSEN ML, Clump DA 2nd, Kubik M, Losego K, et al
    Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.
    Head Neck. 2020 May 18. doi: 10.1002/hed.26256.
    PubMed     Abstract available


  4. VERMA N, Patel S, Osborn V, McBride S, et al
    Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26245.
    PubMed     Abstract available


  5. BOWMAN R, Crosby DL, Sharma A
    Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26260.
    PubMed     Abstract available


  6. QIN T, Koneva LA, Liu Y, Zhang Y, et al
    Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer.
    Head Neck. 2020 May 14. doi: 10.1002/hed.26244.
    PubMed     Abstract available


  7. CHANG CF, Ei-Sayed IH, George JR, Heaton CM, et al
    Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
    Head Neck. 2020 May 13. doi: 10.1002/hed.26249.
    PubMed     Abstract available


  8. PALERI V, Hardman J, Tikka T, Bradley P, et al
    Rapid implementation of an evidence-based remote triaging system for assessment of suspected head and neck cancer referrals and patients on follow up after treatment during the COVID-19 pandemic: A model for international collaboration.
    Head Neck. 2020 May 6. doi: 10.1002/hed.26219.
    PubMed     Abstract available


  9. KIM DH, Kim Y, Kim SW, Hwang SH, et al
    Use of narrowband imaging for the diagnosis and screening of laryngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2020 May 4. doi: 10.1002/hed.26186.
    PubMed     Abstract available


  10. CIVANTOS FJ, Leibowitz JM, Arnold DJ, Stubbs VC, et al
    Ethical Surgical Triage of Head and Neck Cancer Patients during the COVID-19 Pandemic.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26229.
    PubMed     Abstract available


  11. GUPTA A, Arora V, Nair D, Agrawal N, et al
    Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian Scenario.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26227.
    PubMed     Abstract available


  12. LEE AK, FRCSEd RHC, FRCSEd EHL, Cheng HK, et al
    Mitigation of Head and Neck Cancer Service Disruption During COVID-19 in Hong Kong Through Telehealth and Multi-institution Collaboration.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26226.
    PubMed     Abstract available


    April 2020
  13. MASSA ST, Pipkorn P, Jackson RS, Zevallos JP, et al
    Access to a regular medical provider among head and neck cancer survivors.
    Head Neck. 2020 Apr 30. doi: 10.1002/hed.26182.
    PubMed     Abstract available


  14. KU PK, Holsinger FC, Chan JY, Yeung ZC, et al
    Management of Dysphagia in The Head and Neck Cancer Patient during COVID-19 Pandemic: A Practical Strategy.
    Head Neck. 2020 Apr 29. doi: 10.1002/hed.26224.
    PubMed     Abstract available


  15. PRASAD A, Brewster R, Newman JG, Rajasekaran K, et al
    Optimizing your telemedicine visit during the COVID-19 pandemic: Practice guidelines for patients with head and neck cancer.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26197.
    PubMed     Abstract available


  16. SHARMA A, Crosby DL
    Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26216.
    PubMed     Abstract available


  17. SILVERMAN DA, Lin C, Tamaki A, Puram SV, et al
    Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26217.
    PubMed     Abstract available


  18. CHOW VLY, Chan JYW, Ho VWY, Lee GCC, et al
    Conservation of personal protective equipment for head and neck cancer surgery during COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26215.
    PubMed     Abstract available


  19. SINGH AG, Deodhar J, Chaturvedi P
    Navigating the impact of COVID-19 on palliative care for head and neck cancer.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26211.
    PubMed     Abstract available


  20. YAN F, Nguyen SA
    Head and neck cancer: A high-risk population for COVID-19.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26209.
    PubMed    


  21. NOEL CW, Stephens RF, Su JS, Xu W, et al
    Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2020 Apr 25. doi: 10.1002/hed.26181.
    PubMed     Abstract available


  22. BHATTACHARJEE A, Patil VM, Dikshit R, Prabhash K, et al
    Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26196.
    PubMed     Abstract available


  23. SHUMAN AG, Campbell BH
    An Ethical Framework for Head and Neck Cancer Care Impacted by COVID-19.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26193.
    PubMed     Abstract available


  24. WANG L, Cao J, Wang X, Lin E, et al
    Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells.
    Head Neck. 2020 Apr 23. doi: 10.1002/hed.26155.
    PubMed     Abstract available


  25. DAI LB, Yu Q, Zhou SH, Bao YY, et al
    Effect of combination of curcumin and GLUT-1 AS-ODN on radiosensitivity of laryngeal carcinoma through regulating autophagy.
    Head Neck. 2020 Apr 21. doi: 10.1002/hed.26180.
    PubMed     Abstract available


  26. KLIGERMAN MP, Vukkadala N, Tsang RKY, Sunwoo JB, et al
    Managing the Head and Neck Cancer Patient with Tracheostomy or Laryngectomy During the COVID-19 Pandemic.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26171.
    PubMed    


  27. BOAKYE EA, Jenkins W, Sharma A
    Disproportionate impact of COVID-19 Pandemic on Head and Neck Cancer Survivors.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26170.
    PubMed    


  28. CIVANTOS AM, Carey RM, Lichtenstein GR, Lukens JN, et al
    Care of Immunocompromised Patients with Head and Neck Cancer During the COVID-19 Pandemic: Two Challenging and Informative Clinical Cases.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26165.
    PubMed     Abstract available


  29. RASSEKH CH, Jenks CM, Ochroch EA, Douglas JE, et al
    Management of the difficult airway in the COVID-19 pandemic: Illustrative complex head and neck cancer scenario.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26175.
    PubMed     Abstract available


  30. LEE MY, Allen CT
    Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer.
    Head Neck. 2020 Apr 10. doi: 10.1002/hed.26158.
    PubMed     Abstract available


    March 2020
  31. VENGALOOR THOMAS T, Packianathan S, Bhanat E, Albert A, et al
    Oligometastatic head and neck cancer: Comprehensive review.
    Head Neck. 2020 Mar 27. doi: 10.1002/hed.26144.
    PubMed     Abstract available


  32. FRANZ L, Tealdo G, Contro G, Bandolin L, et al
    Biological tumor markers (maspin, CD105, nm23-H1) and disease relapse in laryngeal cancer: cluster analysis.
    Head Neck. 2020 Mar 25. doi: 10.1002/hed.26152.
    PubMed     Abstract available


  33. PARK D, Kim HY, Kim HK, You JY, et al
    Institutional experience of 200 consecutive papillary thyroid carcinoma patients in transoral robotic thyroidectomy surgeries.
    Head Neck. 2020 Mar 25. doi: 10.1002/hed.26149.
    PubMed     Abstract available


  34. HE Y, Zhao Z, Wang Y, Chai J, et al
    Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis.
    Head Neck. 2020 Mar 23. doi: 10.1002/hed.26141.
    PubMed     Abstract available


  35. HUANG T, Su N, Zhang X, Ma S, et al
    Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases.
    Head Neck. 2020 Mar 10. doi: 10.1002/hed.26130.
    PubMed     Abstract available


  36. MEHRA R, Huang H, Seal B, Tse J, et al
    Real-world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno-oncology therapy.
    Head Neck. 2020 Mar 9. doi: 10.1002/hed.26126.
    PubMed     Abstract available


  37. PASALIC D, Betancourt-Cuellar SL, Taku N, Ludmir EB, et al
    Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
    Head Neck. 2020 Mar 4. doi: 10.1002/hed.26117.
    PubMed     Abstract available


  38. JACOMINA LE, Jacinto JKM, Co LBA, Yu KKL, et al
    The Role of postoperative external beam radiotherapy for differentiated thyroid carcinoma: A Systematic review and meta-analysis.
    Head Neck. 2020 Mar 4. doi: 10.1002/hed.26133.
    PubMed     Abstract available


    February 2020
  39. TOWNES TG, Navuluri S, Pytynia KB, Gunn GB, et al
    Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic.
    Head Neck. 2020 Feb 29. doi: 10.1002/hed.26119.
    PubMed     Abstract available


  40. KARSTEN RT, van der Molen L, Hamming-Vrieze O, van Son RJJH, et al
    Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update.
    Head Neck. 2020 Feb 29. doi: 10.1002/hed.26120.
    PubMed     Abstract available


  41. LOFHEDE H, Wertsen M, Havstam C
    Palatal augmentation prostheses in individuals treated for head and neck cancer: Effects on speech and oral transport.
    Head Neck. 2020 Feb 27. doi: 10.1002/hed.26124.
    PubMed     Abstract available


  42. THIBOUW F, Duvillard C, Thibouw D, Bertaut A, et al
    Evaluation of the quality of the information received during head and neck cancer announcement: Prospective two-center study.
    Head Neck. 2020 Feb 24. doi: 10.1002/hed.26109.
    PubMed     Abstract available


  43. WAN Y, Liu H, Zhang M, Huang Z, et al
    Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2020 Feb 12. doi: 10.1002/hed.26104.
    PubMed     Abstract available


  44. TEXAKALIDIS P, Giannopoulos S, Tsouknidas I, Song S, et al
    Prevalence of carotid stenosis following radiotherapy for head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2020 Feb 12. doi: 10.1002/hed.26102.
    PubMed     Abstract available


  45. MALIK A, Nair S, Singh A, Lamba K, et al
    Soft tissue deposit in neck dissection specimen carries a poor prognosis in oral cancer: A matched pair analysis.
    Head Neck. 2020 Feb 11. doi: 10.1002/hed.26103.
    PubMed     Abstract available


  46. BAO X, Liu F, Chen Q, Chen L, et al
    Propensity score analysis exploring the impact of smoking and drinking on the prognosis of patients with oral cancer.
    Head Neck. 2020 Feb 7. doi: 10.1002/hed.26099.
    PubMed     Abstract available


  47. AYLWARD A, Park J, Abdelaziz S, Hunt JP, et al
    Individualized prediction of late-onset dysphagia in head and neck cancer survivors.
    Head Neck. 2020 Feb 7. doi: 10.1002/hed.26039.
    PubMed     Abstract available


  48. TWU CW, Wang WY, Tsou HH, Liu YC, et al
    Effects of Epstein-Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma.
    Head Neck. 2020 Feb 3. doi: 10.1002/hed.26096.
    PubMed     Abstract available


    January 2020
  49. RATURI V, Hojo H, Bhatt MLB, Suhel M, et al
    Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation.
    Head Neck. 2020 Jan 30. doi: 10.1002/hed.26083.
    PubMed     Abstract available


  50. SWIECICKI PL, Li P, Bellile E, Stucken C, et al
    Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
    Head Neck. 2020 Jan 27. doi: 10.1002/hed.26085.
    PubMed     Abstract available


  51. LIU YP, Xie YL, Zou X, You R, et al
    Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma.
    Head Neck. 2020 Jan 24. doi: 10.1002/hed.26090.
    PubMed     Abstract available


  52. SOLDERA EB, Ortigara GB, Bonzanini LIL, Schulz RE, et al
    Clinical and sociodemographic factors associated with oral health-related quality of life in survivors of head and neck cancer.
    Head Neck. 2020 Jan 21. doi: 10.1002/hed.26063.
    PubMed     Abstract available


  53. AHN D, Lee GJ, Sohn JH, Jeon JH, et al
    Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
    Head Neck. 2020 Jan 13. doi: 10.1002/hed.26075.
    PubMed     Abstract available


  54. COGNETTI DM, Villaflor VM, Fakhry C, Miller MC, et al
    Survivorship support in head and neck cancer: American Head and Neck Society survey.
    Head Neck. 2020 Jan 10. doi: 10.1002/hed.26066.
    PubMed     Abstract available


  55. ROMAN BR, Lohia S, Mitra N, Wang MB, et al
    Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.
    Head Neck. 2020 Jan 10. doi: 10.1002/hed.26071.
    PubMed     Abstract available


  56. BAHL A, Bhatia K, Choudhary P, Singhla S, et al
    Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis.
    Head Neck. 2020 Jan 8. doi: 10.1002/hed.26070.
    PubMed     Abstract available


  57. CHEE J, Liu X, Eu D, Loh T, et al
    Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes.
    Head Neck. 2020 Jan 7. doi: 10.1002/hed.26061.
    PubMed     Abstract available


  58. WALL LR, Ward EC, Cartmill B, Hill AJ, et al
    Prophylactic swallowing therapy for patients with head and neck cancer: A three-arm randomized parallel-group trial.
    Head Neck. 2020 Jan 6. doi: 10.1002/hed.26060.
    PubMed     Abstract available


  59. KOUDOUGOU C, Bertin H, Lecaplain B, Badran Z, et al
    Postimplantation radiation therapy in head and neck cancer patients: Literature review.
    Head Neck. 2020 Jan 3. doi: 10.1002/hed.26065.
    PubMed     Abstract available


  60. SULLIVAN CB, Al-Qurayshi Z, Pagedar NA
    Analysis of patients who decline treatment for squamous cell carcinoma of the head and neck: National perspective.
    Head Neck. 2020 Jan 2. doi: 10.1002/hed.26040.
    PubMed     Abstract available


    December 2019
  61. LEE YH, Goo-Yoshino S, Lew HL, Chi WC, et al
    Social participation in head and neck cancer survivors with swallowing disorder: World Health Organization Disability Assessment Schedule 2.0 study.
    Head Neck. 2019 Dec 30. doi: 10.1002/hed.26062.
    PubMed     Abstract available


  62. CHEN Q, Zou X, Ma Y, Liu F, et al
    Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection therapy for the treatment of chyle fistula following neck dissection.
    Head Neck. 2019 Dec 28. doi: 10.1002/hed.26054.
    PubMed     Abstract available


  63. MEHDIZADEH OB, Dhar SI, Evangelista L, Nativ-Zeltzer N, et al
    Prevalence of profound laryngeal sensory neuropathy in head and neck cancer survivors with feeding tube-dependent oropharyngeal dysphagia.
    Head Neck. 2019 Dec 27. doi: 10.1002/hed.26059.
    PubMed     Abstract available


  64. SUN C, Wang Q, Guo Q, Chang Q, et al
    Analysis of patterns and risk factors regarding the onset of nodules in the contralateral thyroid lobe during follow-up ultrasonography among patients after unilateral lobectomy for the treatment of papillary thyroid carcinoma.
    Head Neck. 2019 Dec 24. doi: 10.1002/hed.26056.
    PubMed     Abstract available


  65. RUEGG P, Morand GB, Kudura K, Rupp NJ, et al
    Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUVmax , p16-negativity, and low nodal shrinkage.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26045.
    PubMed     Abstract available


  66. MAKITIE AA, Almangush A, Youssef O, Metsala M, et al
    Exhaled breath analysis in the diagnosis of head and neck cancer.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26043.
    PubMed     Abstract available


  67. SAITO Y, Favorov AV, Forman M, Ren S, et al
    Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 18. doi: 10.1002/hed.26041.
    PubMed     Abstract available


  68. TIAN S, Switchenko JM, Fei T, Press RH, et al
    Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.
    Head Neck. 2019 Dec 16. doi: 10.1002/hed.26042.
    PubMed     Abstract available


  69. YANG TH, Xirasagar S, Cheng YF, Wu CS, et al
    Association between pioglitazone use and head and neck cancer: Population-based case-control study.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26046.
    PubMed     Abstract available


  70. NAGHAVI AO, Kim Y, Yang GQ, Ahmed KA, et al
    Alterations in genetic pathways following radiotherapy for head and neck cancer.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26004.
    PubMed     Abstract available


  71. ROGERS SN, Alvear A, Anesi A, Babin E, et al
    Variations in concerns reported on the patient concerns inventory in patients with head and neck cancer from different health settings across the world.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26027.
    PubMed     Abstract available


  72. DU C, Blanchard P, Even C, Boros A, et al
    Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 4. doi: 10.1002/hed.26021.
    PubMed     Abstract available


    November 2019
  73. WONG ECY, Hung JLC, Ng WT
    Potential pitfalls in incorporating plasma Epstein-Barr virus DNA in the management of nasopharyngeal carcinoma.
    Head Neck. 2019 Nov 28. doi: 10.1002/hed.26018.
    PubMed     Abstract available


  74. MARZILIANO A, Teckie S, Diefenbach MA
    Alcohol-related head and neck cancer: Summary of the literature.
    Head Neck. 2019 Nov 27. doi: 10.1002/hed.26023.
    PubMed     Abstract available


  75. PATEL JJ, Levy DA, Nguyen SA, Knochelmann HM, et al
    Impact of PD-L1 expression and human papillomavirus status in anti-PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma-Systematic review and meta-analysis.
    Head Neck. 2019 Nov 24. doi: 10.1002/hed.26036.
    PubMed     Abstract available


  76. STEPHENS RF, Noel CW, Su JS, Xu W, et al
    Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2019 Nov 24. doi: 10.1002/hed.26031.
    PubMed     Abstract available


  77. AGHAJANZADEH S, Karlsson T, Tuomi L, Finizia C, et al
    The effect of jaw exercises on anxiety and depression in patients with head and neck cancer receiving radiotherapy: Prospective 2-year follow-up study.
    Head Neck. 2019 Nov 22. doi: 10.1002/hed.26012.
    PubMed     Abstract available


  78. COCA-PELAZ A, Rodrigo JP, Suarez C, Nixon IJ, et al
    The risk of second primary tumors in head and neck cancer: A systematic review.
    Head Neck. 2019 Nov 21. doi: 10.1002/hed.26016.
    PubMed     Abstract available


  79. VALERO C, Pardo L, Sansa A, Garcia Lorenzo J, et al
    Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.
    Head Neck. 2019 Nov 21. doi: 10.1002/hed.26010.
    PubMed     Abstract available


  80. PODEUR F, Pommier P, Crozes C, Monchet E, et al
    Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes.
    Head Neck. 2019 Nov 18. doi: 10.1002/hed.26007.
    PubMed     Abstract available


  81. NEVES-SILVA R, Almeida LY, Silveira HA, Colturato CBN, et al
    SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
    Head Neck. 2019 Nov 15. doi: 10.1002/hed.26008.
    PubMed     Abstract available


  82. ZHANG Y, Xu S, Liu W, Wang X, et al
    Rational choice of neck dissection in clinically N0 patients with supraglottic cancer.
    Head Neck. 2019 Nov 14. doi: 10.1002/hed.26014.
    PubMed     Abstract available


  83. WANG L, Yang L, Han S, Zhu J, et al
    Patterns of protein expression in human head and neck cancer cell lines differ after proton vs photon radiotherapy.
    Head Neck. 2019 Nov 11. doi: 10.1002/hed.26005.
    PubMed     Abstract available


  84. BONOMO P, Talamonti C, Desideri I, Marrazzo L, et al
    Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy.
    Head Neck. 2019 Nov 4. doi: 10.1002/hed.25997.
    PubMed     Abstract available


  85. HURTADO-LOPEZ LM, Basurto-Kuba E
    In response: Tailored approach for recurrent laryngeal nerve dissection according to different endoscopic endocrine surgery.
    Head Neck. 2019;41:4062-4063.
    PubMed    


  86. MICCOLI P, Dionigi G
    Tailored approach for recurrent laryngeal nerve dissection according to different endoscopic endocrine surgery.
    Head Neck. 2019;41:4060-4061.
    PubMed    


    October 2019
  87. WILSON TG, Hanna A, Recknagel J, Pruetz BL, et al
    Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation.
    Head Neck. 2019 Oct 27. doi: 10.1002/hed.25983.
    PubMed     Abstract available


  88. HORI Y, Kubota A, Yokose T, Furukawa M, et al
    Association between pathological invasion patterns and late lymph node metastases in patients with surgically treated clinical No early oral tongue carcinoma.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25994.
    PubMed     Abstract available


  89. JANTHARAPATTANA K, Orapipatpong O
    Efficacy of EPA-enriched supplement compared with standard formula on body weight changes in malnourished patients with head and neck cancer undergone surgery: a randomized study.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25987.
    PubMed     Abstract available


  90. GOU X, Duan B, Shi H, Qin L, et al
    The relations of dosimetric parameters with long-term outcomes and late toxicities in advanced T-stage nasopharyngeal carcinoma with IMRT.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25986.
    PubMed     Abstract available


  91. PAIAR F, Cristaudo A, Gonnelli A, Giannini N, et al
    Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review".
    Head Neck. 2019 Oct 21. doi: 10.1002/hed.25982.
    PubMed     Abstract available


  92. NG WT, Lee MC, Fung NT, Wong EC, et al
    Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma.
    Head Neck. 2019 Oct 16. doi: 10.1002/hed.25988.
    PubMed     Abstract available


  93. DOOLEY BJ, Karassawa Zanoni D, Mcgill MR, Awad MI, et al
    Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer.
    Head Neck. 2019 Oct 8. doi: 10.1002/hed.25970.
    PubMed     Abstract available


  94. PARK H, Harries V, McGill MR, Ganly I, et al
    Isthmusectomy in selected patients with well-differentiated thyroid carcinoma.
    Head Neck. 2019 Oct 7. doi: 10.1002/hed.25968.
    PubMed     Abstract available


  95. AMINI A, Verma V, Li R, Vora N, et al
    Factors predicting for patient refusal of head and neck cancer therapy.
    Head Neck. 2019 Oct 4. doi: 10.1002/hed.25966.
    PubMed     Abstract available


  96. KAO HF, Lou PJ
    Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.
    Head Neck. 2019;41 Suppl 1:4-18.
    PubMed     Abstract available


  97. LOU PJ
    Preface for the special issue of "Immunotherapy for head and neck cancers: Current landscapes, emerging biomarkers, and future directions".
    Head Neck. 2019;41 Suppl 1:3.
    PubMed    


  98. CHEN TH, Chang PM, Yang MH
    Novel immune-modulating drugs for advanced head and neck cancer.
    Head Neck. 2019;41 Suppl 1:46-56.
    PubMed     Abstract available


  99. HSIEH JC, Wang HM, Wu MH, Chang KP, et al
    Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy.
    Head Neck. 2019;41 Suppl 1:19-45.
    PubMed     Abstract available


  100. NISHIO N, van Keulen S, van den Berg NS, Lu G, et al
    Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
    Head Neck. 2019 Oct 1. doi: 10.1002/hed.25964.
    PubMed     Abstract available


  101. ORLANDI E, Iacovelli NA, Cavallo A, Resteghini C, et al
    Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression?
    Head Neck. 2019;41:3733-3735.
    PubMed    


    September 2019
  102. BALAGUER M, Pommee T, Farinas J, Pinquier J, et al
    Effects of oral and oropharyngeal cancer on speech intelligibility using acoustic analysis: Systematic review.
    Head Neck. 2019 Sep 30. doi: 10.1002/hed.25949.
    PubMed     Abstract available


  103. HAN JE, Yi SK, Wang S, Erman A, et al
    Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.
    Head Neck. 2019 Sep 14. doi: 10.1002/hed.25955.
    PubMed     Abstract available


  104. WU L, Zhuo S, Zeng W, Liang S, et al
    Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
    Head Neck. 2019 Sep 13. doi: 10.1002/hed.25953.
    PubMed     Abstract available


  105. RODEN D, Daniels K, Metkus J, Goldman R, et al
    Evaluation of oncologic outcomes in head and neck cancer patients >/=80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25950.
    PubMed     Abstract available


  106. MOWERY AJ, Conlin MJ, Clayburgh DR
    Elevated incidence of head and neck cancer in solid organ transplant recipients.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25937.
    PubMed     Abstract available


  107. GIRKAR F, Thiagarajan S, Malik A, Sawhney S, et al
    Factors predisposing to the development of orocutaneous fistula following surgery for oral cancer: Experience from a tertiary cancer center.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25951.
    PubMed     Abstract available


  108. TAM S, Nurgalieva Z, Weber RS, Lewis CM, et al
    Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25936.
    PubMed     Abstract available


  109. BRISSON RJ, Kochanny S, Arshad S, Dekker A, et al
    A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Sep 4. doi: 10.1002/hed.25910.
    PubMed     Abstract available


  110. MASKELL D, Buckley H, Sisson K, Roques T, et al
    In reply to McDowell et al.
    Head Neck. 2019;41:3470-3471.
    PubMed    


  111. MCDOWELL L, Corry J
    Comment on "Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer-Approach with caution".
    Head Neck. 2019;41:3468-3469.
    PubMed    


    August 2019
  112. KARSTEN RT, Al-Mamgani A, Bril SI, Tjon-A-Joe S, et al
    Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer.
    Head Neck. 2019 Aug 31. doi: 10.1002/hed.25938.
    PubMed     Abstract available


  113. XU SY, Yao JJ, Zhou W, Chen L, et al
    Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion.
    Head Neck. 2019 Aug 29. doi: 10.1002/hed.25941.
    PubMed     Abstract available


  114. ELDRIDGE RC, Pugh SL, Trotti A, Hu K, et al
    Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25922.
    PubMed     Abstract available


  115. CHEN JH, Huang WY, Ho CL, Chao TY, et al
    Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25904.
    PubMed     Abstract available


  116. MIMICA X, Hanson M, Patel SG, McGill M, et al
    Salvage surgery for recurrent larynx cancer.
    Head Neck. 2019 Aug 21. doi: 10.1002/hed.25925.
    PubMed     Abstract available


  117. CHO Y, Yoon HI, Lee IJ, Kim JW, et al
    Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes.
    Head Neck. 2019 Aug 20. doi: 10.1002/hed.25928.
    PubMed     Abstract available


  118. TAN AL, Iyer NG, Putri N, Nadkarni N, et al
    Factors driving frequent attendance at emergency departments for patients with head and neck cancer.
    Head Neck. 2019 Aug 18. doi: 10.1002/hed.25916.
    PubMed     Abstract available


  119. SHAH M, Jomaa MK, Ferrarotto R, Yeung SJ, et al
    Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review.
    Head Neck. 2019 Aug 15. doi: 10.1002/hed.25911.
    PubMed     Abstract available


  120. GILL AS, Kinzinger M, Bewley AF, Farwell DG, et al
    Malnutrition evaluation in head and neck cancer patients: Practice patterns among otolaryngologists and radiation oncologists.
    Head Neck. 2019 Aug 12. doi: 10.1002/hed.25909.
    PubMed     Abstract available


  121. LIN DJ, Lam A, Warner L, Paleri V, et al
    Elective neck dissection in patients with radio-recurrent and radio-residual squamous cell carcinoma of the larynx undergoing salvage total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2019 Aug 10. doi: 10.1002/hed.25907.
    PubMed     Abstract available


  122. ALMADORI G, De Corso E, Visconti G, Almadori A, et al
    Impact of internal mammary artery perforator propeller flap in neck resurfacing and fistula closure after salvage larynx cancer surgery: Our experience.
    Head Neck. 2019 Aug 9. doi: 10.1002/hed.25903.
    PubMed     Abstract available


  123. LI H, Li EY, Kejner AE
    Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25897.
    PubMed     Abstract available


  124. MANDAPATHIL M, Lennon P, Ganly I, Patel SG, et al
    Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25905.
    PubMed     Abstract available


  125. MASCARELLA MA, Azzi JL, da Silva SD, Mlynarek A, et al
    Postoperative infection predicts poor survival in locoregionally advanced oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25885.
    PubMed     Abstract available


  126. MCGURK M
    Surgical consensus guidelines on sentinel node biopsy in patients with oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25898.
    PubMed    


  127. KWAN BYM, Khan NM, de Almeida JR, Goldstein D, et al
    Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup.
    Head Neck. 2019 Aug 1. doi: 10.1002/hed.25887.
    PubMed     Abstract available


    July 2019
  128. JAKOB M, Mattes LM, Kuffer S, Unger K, et al
    MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25866.
    PubMed     Abstract available


  129. ORLANDI E, Bonomo P, Ferella L, D'Angelo E, et al
    Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25890.
    PubMed     Abstract available


  130. LE GUEVELOU J, Lebars S, Kammerer E, de Gabory L, et al
    Head and neck cancer during pregnancy.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25877.
    PubMed     Abstract available


  131. MAKITIE AA, Almangush A, Rodrigo JP, Ferlito A, et al
    Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25872.
    PubMed     Abstract available


  132. LU T, Xie X, Guo Q, Zhan S, et al
    Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25865.
    PubMed     Abstract available


  133. PAULI N, Mejersjo C, Fagerberg-Mohlin B, Finizia C, et al
    Temporomandibular disorder in head and neck cancer patients undergoing radiotherapy: Clinical findings and patient-reported symptoms.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25878.
    PubMed     Abstract available


  134. MARIONI G, Nicole L, Cazzador D, Pavone C, et al
    Endoglin (CD105) expression in neurofibromatosis type 2 vestibular schwannoma.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25881.
    PubMed     Abstract available


  135. RASSY E, Nicolai P, Pavlidis N
    Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.
    Head Neck. 2019 Jul 13. doi: 10.1002/hed.25858.
    PubMed     Abstract available


  136. LI X, Zhou J, Chu C, You Q, et al
    Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy.
    Head Neck. 2019 Jul 12. doi: 10.1002/hed.25861.
    PubMed     Abstract available


  137. PETRUZZI G, Zocchi J, Moretto S, Pichi B, et al
    Transoral robotic retropharyngeal lymph node dissection in a recurrent head and neck carcinoma.
    Head Neck. 2019 Jul 11. doi: 10.1002/hed.25874.
    PubMed     Abstract available


  138. ABOUYARED M, Katz AP, Ein L, Ketner J, et al
    Controversies in free tissue transfer for head and neck cancer: A review of the literature.
    Head Neck. 2019 Jul 9. doi: 10.1002/hed.25853.
    PubMed     Abstract available


  139. KIM SH, Lee WH, Seong D, An JH, et al
    The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation.
    Head Neck. 2019 Jul 3. doi: 10.1002/hed.25868.
    PubMed     Abstract available


  140. SU Z, Cao X, Zou G
    Brain and frontal-bone metastasis from nasopharyngeal carcinoma: Case report and literature review.
    Head Neck. 2019 Jul 2. doi: 10.1002/hed.25859.
    PubMed     Abstract available


    June 2019
  141. WANG JR, Nurgalieva Z, Fu S, Tam S, et al
    Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis.
    Head Neck. 2019 Jun 25. doi: 10.1002/hed.25844.
    PubMed     Abstract available


  142. MOORE P, Grinsell D, Lyons B, Hewson I, et al
    Outcomes of dental and craniofacial osseointegrated implantation in head and neck cancer patients.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25845.
    PubMed     Abstract available


  143. WATTERS AL, Cope S, Keller MN, Padilla M, et al
    Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-analysis.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25836.
    PubMed     Abstract available


  144. OH J, Prisman E, Olson R, Berthelet E, et al
    Primary organ preservation vs total laryngectomy for T4a larynx cancer.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25838.
    PubMed     Abstract available


  145. HU Y, Lu T, Huang SH, Lin S, et al
    High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma.
    Head Neck. 2019 Jun 17. doi: 10.1002/hed.25842.
    PubMed     Abstract available


  146. WANG KY, Yang KC, Su FY, Chen YC, et al
    Association between blood pressure and postoperative hematomas in the patients undergoing head and neck cancer reconstruction.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25831.
    PubMed     Abstract available


  147. MIROSEVIC S, Thewes B, van Herpen C, Kaanders J, et al
    Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25812.
    PubMed     Abstract available


  148. POWROZEK T, Brzozowska A, Mazurek M, Mlak R, et al
    Combined analysis of miRNA-181a with phase angle derived from bioelectrical impedance predicts radiotherapy-induced changes in body composition and survival of male patients with head and neck cancer.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25830.
    PubMed     Abstract available


  149. VUONG HG, Ho ATN, Tran TTK, Capdevila J, et al
    Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25832.
    PubMed     Abstract available


    May 2019
  150. CHEN JL, Shen CW, Wang CC, Huang YS, et al
    Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study.
    Head Neck. 2019 May 22. doi: 10.1002/hed.25814.
    PubMed     Abstract available


  151. DELAHAUT G, Temam S, Ambroise J, Tao Y, et al
    Prognostic impact of tumor growth velocity in head and neck squamous cell carcinoma treated by radiotherapy: A pilot study.
    Head Neck. 2019 May 14. doi: 10.1002/hed.25789.
    PubMed     Abstract available


  152. JACOBI C, Gahleitner C, Bier H, Knopf A, et al
    Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
    Head Neck. 2019 May 9. doi: 10.1002/hed.25796.
    PubMed     Abstract available


    April 2019
  153. DANIELS KE, Luginbuhl AJ, Mardekian SK, Cognetti DM, et al
    Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Apr 29. doi: 10.1002/hed.25794.
    PubMed     Abstract available


  154. VAN DE GOOR RMGE, Hardy JCA, van Hooren MRA, Kremer B, et al
    Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25787.
    PubMed     Abstract available


  155. HO YY, Wu TY, Cheng HC, Yang CC, et al
    The significance of tumor budding in oral cancer survival and its relevance to the eighth edition of the American Joint Committee on Cancer staging system.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25780.
    PubMed     Abstract available


  156. THAM T, Machado R, Herman SW, Kraus D, et al
    Personalized prognostication in head and neck cancer: A systematic review of nomograms according to the AJCC precision medicine core (PMC) criteria.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25778.
    PubMed     Abstract available


  157. SONG YC, Hung KF, Liang KL, Chiang JH, et al
    Adjunctive Chinese herbal medicine therapy for nasopharyngeal carcinoma: Clinical evidence and experimental validation.
    Head Neck. 2019 Apr 15. doi: 10.1002/hed.25766.
    PubMed     Abstract available


  158. DURAN G, Aguin S, Cruz R, Barros F, et al
    Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
    Head Neck. 2019 Apr 11. doi: 10.1002/hed.25754.
    PubMed     Abstract available


  159. DE KORT WWB, Maas SLN, Van Es RJJ, Willems SM, et al
    Prognostic value of the nodal yield in head and neck squamous cell carcinoma: A systematic review.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25764.
    PubMed     Abstract available


  160. MIYAGAWA Y, Araki K, Yamashita T, Tanaka S, et al
    Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virus.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25769.
    PubMed     Abstract available


  161. CHEN F, Yan L, Wang J, Lin L, et al
    Upregulated long noncoding RNA ENST00000470447.1 inhibits cell migration and invasion and predicts better disease-free survival of oral cancer.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25765.
    PubMed     Abstract available


  162. PANDA S, Thakar A, Sikka K, Sharma SC, et al
    Role of sternomastoid muscle interposition in concomitant transoral oncologic resection and neck dissection.
    Head Neck. 2019 Apr 4. doi: 10.1002/hed.25753.
    PubMed     Abstract available


    March 2019
  163. YOUNG LK, Vimawala S, Ahmad N, Kushnir V, et al
    Review of inbound medical tourism and legal details of obtaining a visa for treatment of head and neck cancer.
    Head Neck. 2019 Mar 25. doi: 10.1002/hed.25743.
    PubMed     Abstract available


  164. COSTA EFD, Lopes-Aguiar L, Nogueira GS, Lima TRP, et al
    CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 23. doi: 10.1002/hed.25746.
    PubMed     Abstract available


  165. WANG HM, Wu MH, Chang PH, Lin HC, et al
    The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.
    Head Neck. 2019 Mar 22. doi: 10.1002/hed.25744.
    PubMed     Abstract available


  166. MEANS C, Clayburgh DR, Maloney L, Sauer D, et al
    Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25740.
    PubMed     Abstract available


  167. SCHILLING C, Stoeckli SJ, Vigili MG, de Bree R, et al
    Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25739.
    PubMed     Abstract available


  168. KIM H, Shin JH, Hahn SY, Oh YL, et al
    Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25721.
    PubMed     Abstract available


  169. HENRY M, Fuehrmann F, Hier M, Zeitouni A, et al
    Contextual and historical factors for increased levels of anxiety and depression in patients with head and neck cancer: A prospective longitudinal study.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25725.
    PubMed     Abstract available


  170. MORSE RT, Ganju RG, TenNapel MJ, Neupane P, et al
    Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 11. doi: 10.1002/hed.25717.
    PubMed     Abstract available


  171. JANG JY, Kim DS, Park HY, Shin SC, et al
    Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
    Head Neck. 2019 Mar 7. doi: 10.1002/hed.25729.
    PubMed     Abstract available


  172. BAI S, Zhang P, Zhang JC, Shen J, et al
    A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 6. doi: 10.1002/hed.25731.
    PubMed     Abstract available


  173. YASUMATSU R, Wakasaki T, Hashimoto K, Nakashima K, et al
    Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25737.
    PubMed     Abstract available


  174. MOHAMED A, Twardy B, Zordok MA, Ashraf K, et al
    Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: A comparative analysis.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25379.
    PubMed     Abstract available


  175. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25727.
    PubMed     Abstract available


  176. FADEN DL, Concha-Benavente F, Chakka AB, McMichael EL, et al
    Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25726.
    PubMed     Abstract available


  177. MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
    Effectiveness of chemoradiotherapy for radiation-induced bilateral external auditory canal cancer: A case report and literature review.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25728.
    PubMed     Abstract available


  178. VAN SCHAIK JE, Muller Kobold AC, van der Laan BFAM, van der Vegt B, et al
    Squamous cell carcinoma antigen concentration in fine needle aspiration samples: A new method to detect cervical lymph node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25733.
    PubMed     Abstract available


  179. MORATIN J, Metzger K, Safaltin A, Herpel E, et al
    Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 1. doi: 10.1002/hed.25713.
    PubMed     Abstract available


    February 2019
  180. TU HF, Chen MY, Lai JC, Chen YL, et al
    Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25718.
    PubMed     Abstract available


  181. MIRZA AH, Thomas G, Ottensmeier CH, King EV, et al
    Importance of the immune system in head and neck cancer.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25716.
    PubMed     Abstract available


  182. KAO LT, Hung SH, Kao PF, Liu JC, et al
    Inverse association between statin use and head and neck cancer: A population-based case-control study in Han population.
    Head Neck. 2019 Feb 26. doi: 10.1002/hed.25501.
    PubMed     Abstract available


  183. RODRIGUES-JUNIOR DM, Tan SS, Lim SK, de Souza Viana L, et al
    High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression.
    Head Neck. 2019 Feb 25. doi: 10.1002/hed.25510.
    PubMed     Abstract available


  184. ROBBINS KT, Medina J, Ferlito A
    Adding clarity to the historical evolution of the selective neck dissection.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25704.
    PubMed    


  185. STELZLE F, Oetter N, Goellner LT, Adler W, et al
    Speech intelligibility in patients with oral cancer: An objective baseline evaluation of pretreatment function and impairment.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25527.
    PubMed     Abstract available


  186. SMEE R, Williams JR, Kotevski DP
    Surgery is not the only determinant of an outcome in patients with hypopharyngeal carcinoma.
    Head Neck. 2019 Feb 21. doi: 10.1002/hed.25496.
    PubMed     Abstract available


  187. BATES JE, De Leo AN, Morris CG, Amdur RJ, et al
    Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.
    Head Neck. 2019 Feb 20. doi: 10.1002/hed.25695.
    PubMed     Abstract available


  188. WALD P, Grecula J, Walston S, Wei L, et al
    Intraoperative electron beam radiotherapy for locoregionally persistent or recurrent head and neck cancer.
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25673.
    PubMed     Abstract available


  189. TASSLER AB, Gooding WE, Ferris RL
    Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25687.
    PubMed     Abstract available


  190. SHAHA AR
    Recent historic perspective on modified neck dissection.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25700.
    PubMed    


  191. WANG B, Weng YJ, Wang SS, Zhao WX, et al
    Feasibility and safety of needle-assisted endoscopic thyroidectomy with lateral neck dissection for papillary thyroid carcinoma: a preliminary experience.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25705.
    PubMed     Abstract available


  192. KHARIWALA SS, Rubin N, Stepanov I, Nollen N, et al
    "Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.
    Head Neck. 2019 Feb 15. doi: 10.1002/hed.25708.
    PubMed     Abstract available


  193. VAN DEN STEEN L, Van Gestel D, Vanderveken O, Vanderwegen J, et al
    Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patients.
    Head Neck. 2019 Feb 14. doi: 10.1002/hed.25684.
    PubMed     Abstract available


  194. KIM HK, Park D, Kim HY
    Robotic transoral thyroidectomy: Total thyroidectomy and ipsilateral central neck dissection with da Vinci Xi Surgical System.
    Head Neck. 2019 Feb 13. doi: 10.1002/hed.25661.
    PubMed     Abstract available


  195. COCA-PELAZ A, Halmos GB, Strojan P, de Bree R, et al
    The role of age in treatment-related adverse events in patients with head and neck cancer: A systematic review.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25696.
    PubMed     Abstract available


  196. SUN W, Chen L, Huang JQ, Li J, et al
    Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25699.
    PubMed     Abstract available


  197. AVKSHTOL V, Handorf EA, Ridge JA, Leachman BK, et al
    Examining adjuvant radiation dose in head and neck squamous cell carcinoma.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25680.
    PubMed     Abstract available


  198. LIU J, Lu D, Deng D, Wang J, et al
    Free posterior tibial artery perforator flap for 2-stage tracheal reconstruction in patients after resection of well-differentiated thyroid carcinoma invading the trachea.
    Head Neck. 2019 Feb 6. doi: 10.1002/hed.25675.
    PubMed     Abstract available


  199. HUTCHISON AR, Cartmill B, Wall LR, Ward EC, et al
    Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: A systematized scoping review.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25688.
    PubMed     Abstract available


  200. MUELLER SA, Riggauer J, Elicin O, Blaser D, et al
    Patients' preferences concerning follow-up after curative head and neck cancer treatment: A cross-sectional pilot study.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25686.
    PubMed     Abstract available


  201. LI L, Sun Z, Huang X, Li X, et al
    Role of c-Met expression on prognosis of head and neck cancer: A literature review and meta-analysis.
    Head Neck. 2019 Feb 1. doi: 10.1002/hed.25655.
    PubMed     Abstract available


    January 2019
  202. STRIETH S, Ernst BP, Both I, Hirth D, et al
    Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer.
    Head Neck. 2019 Jan 31. doi: 10.1002/hed.25474.
    PubMed     Abstract available


  203. BUSSU F, Tagliaferri L, Mattiucci G, Parrilla C, et al
    HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25646.
    PubMed     Abstract available


  204. LANG S, Schimansky S, Beynon R, Penfold C, et al
    Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25660.
    PubMed     Abstract available


  205. ARBAB M, Margalit DN, Tishler RB, Rabinowits G, et al
    Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.
    Head Neck. 2019 Jan 29. doi: 10.1002/hed.25663.
    PubMed     Abstract available


  206. SWEGAL WC, Iwata AJ, Chang SS
    Developing a patient driven head and neck cancer care pathway.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25590.
    PubMed    


  207. MENDEZ LC, Conrad T, Lee J, Smith B, et al
    Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25624.
    PubMed     Abstract available


  208. DEN TOOM IJ, Janssen LM, van Es RJJ, Karagozoglu KH, et al
    Depth of invasion in patients with early stage oral cancer staged by sentinel node biopsy.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25665.
    PubMed     Abstract available


  209. RILEY CA, Marino MJ, Hsieh MC, Wu EL, et al
    Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease.
    Head Neck. 2019 Jan 25. doi: 10.1002/hed.25600.
    PubMed     Abstract available


  210. KLIGERMAN MP, Sethi RKV, Kozin ED, Gray ST, et al
    Morbidity and mortality among patients with head and neck cancer in the emergency department: A national perspective.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25534.
    PubMed     Abstract available


  211. MENNINI FS, Marcellusi A, Fabiano G, Platini F, et al
    Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25481.
    PubMed     Abstract available


  212. BUTTERWORTH CJ
    Primary vs secondary zygomatic implant placement in patients with head and neck cancer-A 10-year prospective study.
    Head Neck. 2019 Jan 21. doi: 10.1002/hed.25645.
    PubMed     Abstract available


  213. SOOD A, Wykes J, Roshan D, Wang LY, et al
    A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 19. doi: 10.1002/hed.25599.
    PubMed     Abstract available


  214. MIRABILE A, Miceli R, Calderone RG, Locati L, et al
    Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25636.
    PubMed     Abstract available


  215. KRAAIJENGA SA, Hamming-Vrieze O, Verheijen S, Lamers E, et al
    Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25573.
    PubMed     Abstract available


  216. HUANG HI, Chen CH, Wang SH, Wang LH, et al
    Effects of APE1 Asp148Glu polymorphisms on OPMD malignant transformation, and on susceptibility to and overall survival of oral cancer in Taiwan.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25576.
    PubMed     Abstract available


  217. FAGAN JJ, Otiti J, Aswani J, Konney A, et al
    African head and neck fellowships: A model for a sustainable impact on head and neck cancer care in developing countries.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25615.
    PubMed     Abstract available


  218. PAVON MA, Arroyo-Solera I, Leon X, Tellez-Gabriel M, et al
    The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25623.
    PubMed     Abstract available


  219. CABEZAS-CAMARERO S, Garcia-Barberan V, Saiz-Pardo Sanz M, Cabrera-Martin MN, et al
    Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25635.
    PubMed     Abstract available


  220. SU WW, Su CW, Chang DC, Chuang SL, et al
    Impact of varying anatomic sites on advanced stage and survival of oral cancer: A 9-year prospective cohort of 27 717 cases.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25579.
    PubMed     Abstract available


  221. BUGTER O, van Iwaarden DLP, Dronkers EAC, de Herdt MJ, et al
    Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25595.
    PubMed     Abstract available


  222. MEHTA V, Ow TJ, Kim S, Tharakan T, et al
    Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25596.
    PubMed     Abstract available


  223. SINGER S, Amdal CD, Hammerlid E, Tomaszewska IM, et al
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25609.
    PubMed     Abstract available


  224. LEE JW, Ban MJ, Park JH, Lee SM, et al
    Visceral adipose tissue volume and CT-attenuation as prognostic factors in patients with head and neck cancer.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25605.
    PubMed     Abstract available


  225. BECKHAM TH, Leeman J, Jillian Tsai C, Riaz N, et al
    Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: A series of 9 cases and review of the literature.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25577.
    PubMed     Abstract available


  226. CHAN JW, Yeh I, El-Sayed IH, Algazi AP, et al
    Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25613.
    PubMed     Abstract available


  227. VAN DAELE DJ, Langmore SE, Krisciunas GP, Lazarus CL, et al
    The impact of time after radiation treatment on dysphagia in patients with head and neck cancer enrolled in a swallowing therapy program.
    Head Neck. 2019 Jan 10. doi: 10.1002/hed.25344.
    PubMed     Abstract available


  228. TESHIMA M, Otsuki N, Shinomiya H, Morita N, et al
    Impact of retropharyngeal lymph node dissection in the surgical treatment of hypopharyngeal cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25608.
    PubMed     Abstract available


  229. XIANG ZZ, Liu F, Yan RN, Zeng YY, et al
    The prognostic value of volumetric reduction of the target lesions after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25620.
    PubMed     Abstract available


  230. IWATA AJ, Olden HA, Kippen KE, Swegal WC, et al
    A flexible model for patient engagement: Achieving quality outcomes and building a research agenda for head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25584.
    PubMed     Abstract available


  231. WHITE JM, Panchal NH, Wehler CJ, Bestgen SC, et al
    Department of Veterans Affairs Consensus: Preradiation dental treatment guidelines for patients with head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25519.
    PubMed     Abstract available


  232. INGARFIELD K, McMahon AD, Douglas CM, Savage SA, et al
    Determinants of long-term survival in a population-based cohort study of patients with head and neck cancer from Scotland.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25630.
    PubMed     Abstract available


  233. MONTES DE OCA MK, Nye A, Porter C, Collins J, et al
    Head and neck cancer PEG site metastases: Association with PEG placement method.
    Head Neck. 2019 Jan 7. doi: 10.1002/hed.25564.
    PubMed     Abstract available


  234. DENARO AN, Merlano MC
    Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25418.
    PubMed     Abstract available


  235. MAYFIELD JD, Mercado CE, Kaye FJ, Mendenhall WM, et al
    Cetuximab-associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25528.
    PubMed     Abstract available


    December 2018
  236. LIN CS, Chen YW, Liu SC, Tsao CC, et al
    Treatment outcomes with whole-field versus split-field intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.25328.
    PubMed     Abstract available


  237. GILL A, Givi BB, Moore MG
    AHNS Series - Do you know your guidelines?: Assessment and management of malnutrition in patients with head and neck cancer: A review of the NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines((R)) ).
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.24866.
    PubMed     Abstract available


  238. YANG L, Huang Y, Zhou L, Dai Y, et al
    High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25583.
    PubMed     Abstract available


  239. RAMOS-GARCIA P, Gonzalez-Moles MA, Ayen A, Gonzalez-Ruiz L, et al
    Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25632.
    PubMed     Abstract available


  240. TIAN YM, Liu MZ, Zeng L, Bai L, et al
    Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25545.
    PubMed     Abstract available


  241. BUGTER O, van de Ven SEM, Hardillo JA, Bruno MJ, et al
    Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25548.
    PubMed     Abstract available


  242. MIRZA AH, Aylin P, Middleton S, King EV, et al
    Impact of social deprivation on the outcome of major head and neck cancer surgery in England: A national analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25461.
    PubMed     Abstract available


  243. ALVES-PAIVA RM, Gutierrez-Rodrigues F, Pereira-Martins DA, Figueiredo DLA, et al
    Short telomere length in peripheral blood leukocytes in head and neck cancer: Findings in a Brazilian cohort.
    Head Neck. 2018 Dec 27. doi: 10.1002/hed.25472.
    PubMed     Abstract available


  244. CHOI SW, Ko H
    Primary Ewing sarcoma of the squamous temporal bone with intracranial and extracranial extension: A rare cause of sudden sensorineural hearing loss.
    Head Neck. 2018 Dec 24. doi: 10.1002/hed.25449.
    PubMed     Abstract available


  245. HOLLOWS R, Wei W, Cazier JB, Mehanna H, et al
    Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25537.
    PubMed     Abstract available


  246. CAO C, Wei Q, Tang X, Jia Y, et al
    PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: A substudy of a randomized phase III trial.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25601.
    PubMed     Abstract available


  247. TANDON S, Gairola M, Ahlawat P, Karimi AM, et al
    Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25586.
    PubMed     Abstract available


  248. FATTOUH M, Chang GY, Ow TJ, Shifteh K, et al
    Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25420.
    PubMed     Abstract available


  249. DI MAIO P, Iocca O, De Virgilio A, Ferreli F, et al
    Role of palatine tonsillectomy in the diagnostic workup of head and neck squamous cell carcinoma of unknown primary origin: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 21. doi: 10.1002/hed.25522.
    PubMed     Abstract available


  250. KWON DI, Miles BA
    Hypopharyngeal carcinoma: Do you know your guidelines?
    Head Neck. 2018 Dec 20. doi: 10.1002/hed.24752.
    PubMed     Abstract available


  251. VAN DER GEER SJ, van Rijn PV, Kamstra JI, Langendijk JA, et al
    Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25369.
    PubMed     Abstract available


  252. WANG L, Han S, Zhu J, Wang X, et al
    Proton versus photon radiation-induced cell death in head and neck cancer cells.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25357.
    PubMed     Abstract available


  253. KABARRITI R, Baliga S, Ohri N, Guha C, et al
    Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25476.
    PubMed     Abstract available


  254. IBRAHIM MY, Nunez MI, Harun N, Lee JJ, et al
    PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25350.
    PubMed     Abstract available


  255. WANG K, Moon DH, Amdur RJ, Dagan R, et al
    Shoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trials.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25535.
    PubMed     Abstract available


  256. EGYUD M, Sridhar P, Devaiah A, Yamada E, et al
    Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25563.
    PubMed     Abstract available


  257. PLASCHKE CC, Johannesen HH, Hansen RH, Hendel HW, et al
    The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25454.
    PubMed     Abstract available


  258. SLAVIK M, Shatokhina T, Sana J, Ahmad P, et al
    Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25533.
    PubMed     Abstract available


  259. KUBOKI A, Kanaya H, Nakayama T, Konno W, et al
    Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25565.
    PubMed     Abstract available


  260. LEE YA, Li S, Chen Y, Li Q, et al
    Tobacco smoking, alcohol drinking, betel quid chewing, and the risk of head and neck cancer in an East Asian population.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25383.
    PubMed     Abstract available


  261. WANG Y, Xie D, Wang Z, Zhang X, et al
    Kinetics of indocyanine green: Optimizing tumor to normal tissue fluorescence in image-guided oral cancer surgery applications.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25541.
    PubMed     Abstract available


  262. ODENTHAL J, Friedl P, Takes RP
    Compatibility of CO2 laser surgery and fluorescence detection in head and neck cancer cells.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25547.
    PubMed     Abstract available


  263. KARABULUT B
    AHNS series: Do you know our guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25491.
    PubMed    


  264. PAGEDAR NA, Davis AB, Sperry SM, Charlton ME, et al
    Population analysis of socioeconomic status and otolaryngologist distribution on head and neck cancer outcomes.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25521.
    PubMed     Abstract available


  265. PAKKANEN PP, Aaltonen LM, Sorsa TA, Tervahartiala TI, et al
    Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25459.
    PubMed     Abstract available


  266. RUUSKANEN M, Irjala H, Minn H, Vahlberg T, et al
    Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25450.
    PubMed     Abstract available


  267. ARRESE LC, Schieve HJ, Graham JM, Stephens JA, et al
    Relationship between oral intake, patient perceived swallowing impairment, and objective videofluoroscopic measures of swallowing in patients with head and neck cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25542.
    PubMed     Abstract available


  268. GUEZENNEC C, Robin P, Orlhac F, Bourhis D, et al
    Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25433.
    PubMed     Abstract available


  269. SCHIMANSKY S, Lang S, Beynon R, Penfold C, et al
    Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25543.
    PubMed     Abstract available


  270. ZHU Y, Liu H, Xie N, Liu X, et al
    Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25462.
    PubMed     Abstract available


  271. TAMAKI A
    HED-17-0417-AHNS series: Do you know your guidelines? A review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25448.
    PubMed    


  272. GAO W, Wong TS, Lv KX, Zhang MJ, et al
    Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25544.
    PubMed     Abstract available


  273. TUMATI V, Hoang L, Sumer BD, Truelson JM, et al
    Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancer.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25457.
    PubMed     Abstract available


  274. SHAHID N, Iqbal A, Siddiqui AJ, Shoaib M, et al
    Plasma metabolite profiling and chemometric analyses of tobacco snuff dippers and patients with oral cancer: Relationship between metabolic signatures.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25511.
    PubMed     Abstract available


  275. RODNER E, Bocklitz T, von Eggeling F, Ernst G, et al
    Fully convolutional networks in multimodal nonlinear microscopy images for automated detection of head and neck carcinoma: A pilot study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25489.
    PubMed     Abstract available


  276. KIM TH, Lee IJ, Kim JH, Lee CG, et al
    High-dose versus standard-dose radiation therapy for cervical esophageal cancer: A retrospective single-institution study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25483.
    PubMed     Abstract available


  277. QUATRE R, Jacquet T, Atallah I, Tillement O, et al
    Evaluation of the theranostic properties of gadolinium-based nanoparticles for head and neck cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25460.
    PubMed     Abstract available


  278. PANTVAIDYA G, Sivasanker M, Ranganathan P, Pai P, et al
    Prospective cross-sectional study assessing prevalence and factors affecting trismus after multimodal treatment for oral cancers.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25464.
    PubMed     Abstract available


  279. LADANYI A, Kapuvari B, Papp E, Toth E, et al
    Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25546.
    PubMed     Abstract available


  280. ARROYO-SOLERA I, Pavon MA, Leon X, Lopez M, et al
    Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25437.
    PubMed     Abstract available


  281. MIYAMARU S, Minoda R, Kodama N
    Long-term changes in vocal function after supracricoid partial laryngectomy with cricohyoidoepiglottopexy for laryngeal cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25487.
    PubMed     Abstract available


  282. LUMLEY CJ, Kaffenberger TM, Desale S, Tefera E, et al
    Post-diagnosis aspirin use and survival in veterans with head and neck cancer.
    Head Neck. 2018 Dec 11. doi: 10.1002/hed.25518.
    PubMed     Abstract available


  283. FANG FM, Huang TL, Lin YH, Chien CY, et al
    Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25551.
    PubMed     Abstract available


  284. KUWABARA H, Toriihara A, Yuasa-Nakagawa K, Toda K, et al
    Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25490.
    PubMed     Abstract available


  285. YANG CY, Lin CK, Hsieh CC, Tsao CH, et al
    Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25554.
    PubMed     Abstract available


  286. LEE JH, Chun YS, Chung YS
    Extent of lateral neck dissection for papillary thyroid microcarcinomas.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25570.
    PubMed     Abstract available


  287. RYU HJ, Kim EK, Cho BC, Yoon SO, et al
    Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25507.
    PubMed     Abstract available


  288. MCSPADDEN R, Zender C, Eskander A
    AHNS series: Do you know your guidelines? Guideline recommendations for recurrent and persistent head and neck cancer after primary treatment.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25443.
    PubMed     Abstract available


  289. CHOI JB, Lee SG, Kim MJ, Kim TH, et al
    Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25356.
    PubMed     Abstract available


  290. OKAZAKI E, Kawabe J, Oishi M, Hosono M, et al
    Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25429.
    PubMed     Abstract available


  291. HUTCHESON KA, Nurgalieva Z, Zhao H, Gunn GB, et al
    Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25412.
    PubMed     Abstract available


  292. ROTMAN A, Kerr SJ, Giddings CEB
    Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25561.
    PubMed     Abstract available


  293. DRIESSEN CML, Leijendeckers J, Snik A, van der Graaf WTA, et al
    Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25434.
    PubMed     Abstract available


  294. VILASECA I, Nogues-Sabate A, Aviles-Jurado FX, Berenguer J, et al
    Factors of local recurrence and organ preservation with transoral laser microsurgery in laryngeal carcinomas; CHAID decision-tree analysis.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25422.
    PubMed     Abstract available


  295. VON DER GRUN J, Kohn J, Loutfi-Krauss B, Blanck O, et al
    Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2max ) of >180 Gy for patients with recurrent head and neck cancer.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25428.
    PubMed     Abstract available


    November 2018
  296. PAGEDAR NA, Fowlkes JW, Sheffield AM
    Operative technique: Lateral neck dissection.
    Head Neck. 2018 Nov 26. doi: 10.1002/hed.25348.
    PubMed    


  297. WONG ET, Dmytriw AA, Yu E, Waldron J, et al
    (18) F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.
    Head Neck. 2018 Nov 20. doi: 10.1002/hed.25513.
    PubMed     Abstract available


  298. BOSSI P, Miceli R, Benasso M, Corvo R, et al
    Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials.
    Head Neck. 2018 Nov 17. doi: 10.1002/hed.25389.
    PubMed     Abstract available


  299. PARK JC, Gourin CG, Kiess AP, Mehra R, et al
    Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States.
    Head Neck. 2018 Nov 13. doi: 10.1002/hed.25333.
    PubMed     Abstract available


  300. TRUONG AT, Truong DT, Rahlfs TF
    TRS score: A proposed mnemonic for airway assessment and management in patients with head and neck cancers.
    Head Neck. 2018 Nov 2. doi: 10.1002/hed.25502.
    PubMed    


    October 2018
  301. ANSCHUETZ L, Visini M, Shelan M, Elicin O, et al
    Risk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservation.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25373.
    PubMed     Abstract available


  302. LEON X, Pardo L, Sansa A, Fernandez A, et al
    Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25390.
    PubMed     Abstract available


  303. ZHANG N, Fielding R, Soong I, Chan KK, et al
    Illness perceptions as predictors of psychological distress among head and neck cancer survivors: a longitudinal study.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25343.
    PubMed     Abstract available


  304. KILIC S, Kilic SS, Hsueh WD, Eloy JA, et al
    Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25360.
    PubMed     Abstract available


  305. SON HJ, Kim JK, Jung YD, Jang GH, et al
    Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25354.
    PubMed     Abstract available


  306. KOGASHIWA Y, Inoue H, Kuba K, Araki R, et al
    Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25353.
    PubMed     Abstract available


  307. HAMILTON SN, Tran E, Berthelet E, Wu J, et al
    Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
    Head Neck. 2018 Oct 8. doi: 10.1002/hed.25352.
    PubMed     Abstract available


    September 2018
  308. SCRIMGER RA, Seikaly H, Vos LJ, Harris J, et al
    Combination of submandibular salivary gland transfer and intensity-modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck cancer.
    Head Neck. 2018 Sep 3. doi: 10.1002/hed.25339.
    PubMed     Abstract available


    August 2018
  309. DOMINGUES CSDC, Serambeque BP, Laranjo Candido MS, Marto CMM, et al
    Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer.
    Head Neck. 2018 Aug 18. doi: 10.1002/hed.25381.
    PubMed     Abstract available


  310. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25366.
    PubMed     Abstract available


  311. KARATAS OF
    Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25361.
    PubMed     Abstract available


    July 2018
  312. HONG YT, Hong KH
    Identification of lymphatic channels in the tracheoesophageal groove during central neck dissection for thyroid cancer.
    Head Neck. 2018 Jul 26. doi: 10.1002/hed.25125.
    PubMed     Abstract available


    June 2018
  313. MARIONI G, Cappellesso R, Ottaviano G, Fasanaro E, et al
    Nuclear nonmetastatic protein 23-H1 expression and epithelial-mesenchymal transition in laryngeal carcinoma: A pilot investigation.
    Head Neck. 2018 Jun 28. doi: 10.1002/hed.25188.
    PubMed     Abstract available


  314. LEBO NL, Griffiths R, Hall S, Dimitroulakos J, et al
    Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.
    Head Neck. 2018 Jun 22. doi: 10.1002/hed.25152.
    PubMed     Abstract available


  315. OOFT ML, van Ipenburg J, van de Loo RJM, de Jong R, et al
    Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
    Head Neck. 2018 Jun 21. doi: 10.1002/hed.25195.
    PubMed     Abstract available


    May 2018
  316. THAM T, Bardash Y, Herman SW, Costantino PD, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 May 14. doi: 10.1002/hed.25324.
    PubMed     Abstract available


  317. WU JS, Tsai YC, Jian JJ, Chen HH, et al
    Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25205.
    PubMed     Abstract available


  318. LANDEEN KC, Spanos WC, Gromer L
    Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25119.
    PubMed     Abstract available


  319. ANDERSON NJ, Jackson JE, Smith JG, Wada M, et al
    Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25316.
    PubMed     Abstract available


  320. TRIVEDI NP
    Oral cancer involving masticator space (T4b): Review of literature and future directions.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25211.
    PubMed     Abstract available


  321. SUCCO G, Crosetti E, Bertolin A, Piazza C, et al
    Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of different pathologic tumor subcategories.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25176.
    PubMed     Abstract available


  322. ALAHMAD YM, Aljaber M, Saleh AI, Yalcin HC, et al
    Effect of cell-phone radiofrequency on angiogenesis and cell invasion in human head and neck cancer cells.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25210.
    PubMed     Abstract available


  323. SONG JSA, Moolman N, Burrell S, Rajaraman M, et al
    Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25204.
    PubMed     Abstract available


  324. MULCAHY CF, Mohamed ASR, Kanwar A, Hutcheson KA, et al
    Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25200.
    PubMed     Abstract available


  325. ONO T, Azuma K, Kawahara A, Sasada T, et al
    Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25189.
    PubMed     Abstract available


    April 2018
  326. NAIR D, Mair M, Singhvi H, Mishra A, et al
    Perineural invasion: Independent prognostic factor in oral cancer that warrants adjuvant treatment.
    Head Neck. 2018 Apr 29. doi: 10.1002/hed.25170.
    PubMed     Abstract available


  327. HO JC, Phan J
    Reirradiation of head and neck cancer using modern highly conformal techniques.
    Head Neck. 2018 Apr 23. doi: 10.1002/hed.25180.
    PubMed     Abstract available


  328. BERNSTEIN LJ, Pond GR, Gan HK, Tirona K, et al
    Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
    Head Neck. 2018 Apr 17. doi: 10.1002/hed.25198.
    PubMed     Abstract available


  329. FAN CY, Jen YM, Su YC, Chao HL, et al
    Association between nasopharyngeal carcinoma and risk of optic neuropathy: A population-based cohort study.
    Head Neck. 2018 Apr 16. doi: 10.1002/hed.25177.
    PubMed     Abstract available


    March 2018
  330. SHINGLER E, Robles LA, Perry R, Penfold C, et al
    Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia.
    Head Neck. 2018 Mar 30. doi: 10.1002/hed.25138.
    PubMed     Abstract available


  331. HAQUE SU, Niu L, Kuhnell D, Hendershot J, et al
    Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 25. doi: 10.1002/hed.25136.
    PubMed     Abstract available


  332. HEGDE JV, Demanes DJ, Veruttipong D, Chin RK, et al
    Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25137.
    PubMed     Abstract available


  333. KIM HK, Lee I, Lee J, Chang HS, et al
    BRAF(wild) papillary thyroid carcinoma has two distinct mRNA expression patterns with different clinical behaviors.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25151.
    PubMed     Abstract available


  334. RHOTEN BA, Murphy BA, Dietrich MS, Ridner SH, et al
    Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25129.
    PubMed     Abstract available


  335. LUCIONI M, Lionello M, Salis G, Bertolin A, et al
    Bocca's hemipharyngo-total laryngectomy for hypopharyngeal carcinoma to avoid reconstruction with a pedicled flap.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25124.
    PubMed     Abstract available


  336. CONDELLO V, Macerola E, Ugolini C, De Napoli L, et al
    Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25155.
    PubMed     Abstract available


  337. MCEWEN SE, Dunphy C, Rios JN, Davis AM, et al
    Evaluation of a rehabilitation planning consult for survivors of head and neck cancer.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25113.
    PubMed     Abstract available


  338. PAYNE K, Spruce R, Beggs A, Sharma N, et al
    Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25140.
    PubMed     Abstract available


  339. WANG CI, Yu CJ, Huang Y, Yi JS, et al
    Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1beta-induced matrix metalloproteinase expression in oral cancer.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25145.
    PubMed     Abstract available


  340. KIM H, Vargo JA, Beriwal S, Clump DA, et al
    Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25142.
    PubMed     Abstract available


  341. SUZUKI S, Yasunaga H, Matsui H, Fushimi K, et al
    Postoperative mechanical bowel obstruction after pharyngolaryngectomy for hypopharyngeal cancer: Retrospective analysis using a Japanese inpatient database.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25139.
    PubMed     Abstract available


  342. YU F, Lu Y, Petersson F, Wang DY, et al
    Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25131.
    PubMed     Abstract available


  343. DAHER T, Tur MK, Brobeil A, Etschmann B, et al
    Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25041.
    PubMed     Abstract available


  344. WANG X, Li Y, Gao Y, Ouyang D, et al
    Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy predictors and prognostic factors.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25130.
    PubMed     Abstract available


  345. MIZUSHIMA T, Ohnishi S, Shimizu Y, Hatanaka Y, et al
    Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25126.
    PubMed     Abstract available


  346. VUONG HG, Odate T, Duong UNP, Mochizuki K, et al
    Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25123.
    PubMed     Abstract available


  347. LU J, Chen XM, Huang HR, Zhao FP, et al
    Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 1. doi: 10.1002/hed.25104.
    PubMed     Abstract available


    February 2018
  348. PENFOLD CM, Thomas SJ, Waylen A, Ness AR, et al
    Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from head and neck 5000.
    Head Neck. 2018 Feb 27. doi: 10.1002/hed.25116.
    PubMed     Abstract available


  349. HAMSTRA DA, Lee KC, Eisbruch A, Sunkara P, et al
    Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer.
    Head Neck. 2018 Feb 23. doi: 10.1002/hed.25115.
    PubMed     Abstract available


  350. DANILOVIC DLS, de Mello ES, Frazzato EST, Wakamatsu A, et al
    Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
    Head Neck. 2018 Feb 22. doi: 10.1002/hed.25105.
    PubMed     Abstract available


  351. MORISADA M, Chamberlin M, Allen C
    Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.
    Head Neck. 2018 Feb 20. doi: 10.1002/hed.25101.
    PubMed     Abstract available


  352. OSBORN VW, Givi B, Rineer J, Roden D, et al
    Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25103.
    PubMed     Abstract available


  353. CHAN SL, Ng LS, Goh X, Siow CH, et al
    Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25112.
    PubMed     Abstract available


  354. GINGERICH MA, Smith JD, Michmerhuizen NL, Ludwig M, et al
    Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.
    Head Neck. 2018 Feb 10. doi: 10.1002/hed.25057.
    PubMed     Abstract available


  355. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25100.
    PubMed     Abstract available


  356. KIRKE DN, Qureshi MM, Kamran SC, Ezzat W, et al
    Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25087.
    PubMed     Abstract available


  357. MURTHY SP, Balasubramanian D, Subramaniam N, Nair G, et al
    Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25099.
    PubMed     Abstract available


  358. HALL SF, Griffiths RJ
    Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study.
    Head Neck. 2018 Feb 7. doi: 10.1002/hed.25073.
    PubMed     Abstract available


  359. BACK LJJ, Aro K, Tapiovaara L, Vikatmaa P, et al
    Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis.
    Head Neck. 2018 Feb 5. doi: 10.1002/hed.25093.
    PubMed     Abstract available


  360. GUTTMANN DM, Kobie J, Grover S, Lin A, et al
    National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25091.
    PubMed     Abstract available


  361. TALMI YP, Takes RP, Alon EE, Nixon IJ, et al
    Prognostic value of lymph node ratio in head and neck squamous cell carcinoma.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25080.
    PubMed     Abstract available


  362. LIN PJ, Twu CW, Liu YC, Lin TY, et al
    Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25084.
    PubMed     Abstract available


  363. TIRELLI G, Bergamini PR, Scardoni A, Gatto A, et al
    Intraoperative monitoring of marginal mandibular nerve during neck dissection.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25078.
    PubMed     Abstract available


    January 2018
  364. VALLS-MATEUS M, Nogues-Sabate A, Blanch JL, Bernal-Sprekelsen M, et al
    Narrow band imaging for head and neck malignancies: Lessons learned from mistakes.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25088.
    PubMed     Abstract available


  365. NAKAYAMA M, Gosho M, Hirose Y, Nishimura B, et al
    Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25085.
    PubMed     Abstract available


  366. ZENGA J, Pipkorn P, Graboyes EM, Martin EJ, et al
    Oncologic outcomes of extended neck dissections in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2018 Jan 29. doi: 10.1002/hed.25060.
    PubMed     Abstract available


  367. AEBERHARD C, Mayer C, Meyer S, Mueller SA, et al
    Effect of preoperative immunonutrition on postoperative short-term outcomes of patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 24. doi: 10.1002/hed.25072.
    PubMed     Abstract available


  368. VASAN K, Low TH, Gupta R, Ashford B, et al
    Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25066.
    PubMed     Abstract available


  369. LAM JKS, Sundaresan P, Gebski V, Veness MJ, et al
    Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25069.
    PubMed     Abstract available


  370. BAUMEISTER P, Baumuller K, Harreus U, Reiter M, et al
    Evaluation of margins in head and neck squamous cell carcinoma from the surgeon's perspective.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25061.
    PubMed     Abstract available


  371. MASCARELLA MA, Mannard E, Daniela Silva Wurzba S, Zeitouni A, et al
    Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25075.
    PubMed     Abstract available


  372. ESKANDER A, Strigenz D, Seim N, Ozer E, et al
    Submental artery island flap with simultaneous level I neck dissection.
    Head Neck. 2018 Jan 13. doi: 10.1002/hed.25044.
    PubMed     Abstract available


  373. REN Y, Deschler DG, Sajed D, Durand ML, et al
    Case of late-onset, relapsing surgical site infection related to a venous coupler placed during free flap reconstruction for major head and neck cancer.
    Head Neck. 2018 Jan 12. doi: 10.1002/hed.25043.
    PubMed     Abstract available


  374. OKER N, Verillaud B, Wassef M, Froelich S, et al
    Ethmoidal adenocarcinoma treated by exclusive endoscopic approach: Focus on learning curve and modification of management.
    Head Neck. 2018;40:126-136.
    PubMed     Abstract available


  375. LEE DJ, Chin CJ, Hong CJ, Perera S, et al
    Outpatient versus inpatient thyroidectomy: A systematic review and meta-analysis.
    Head Neck. 2018;40:192-202.
    PubMed     Abstract available


  376. KNIGGE MA, Thibeault SL
    Swallowing outcomes after cricopharyngeal myotomy: A systematic review.
    Head Neck. 2018;40:203-212.
    PubMed     Abstract available


  377. MATTAVELLI D, Schreiber A, Villaret AB, Accorona R, et al
    Complications and donor site morbidity of 3-layer reconstruction with iliotibial tract of the anterior skull base: Retrospective analysis of 186 patients.
    Head Neck. 2018;40:63-69.
    PubMed     Abstract available


  378. LANSU J, Klop WM, Heemsbergen W, Navran A, et al
    Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy.
    Head Neck. 2018;40:86-93.
    PubMed     Abstract available


    December 2017
  379. AVINCSAL MO, Shinomiya H, Teshima M, Kubo M, et al
    Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer.
    Head Neck. 2017 Dec 29. doi: 10.1002/hed.25050.
    PubMed     Abstract available


  380. DEJACO D, Steinbichler T, Schartinger VH, Fischer N, et al
    Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
    Head Neck. 2017 Dec 22. doi: 10.1002/hed.25040.
    PubMed     Abstract available


  381. SON HJ, Roh JL, Choi SH, Nam SY, et al
    Nutritional and hematologic markers as predictors of risk of surgical site infection in patients with head and neck cancer undergoing major oncologic surgery.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25031.
    PubMed     Abstract available


  382. SANABRIA A, Kowalski LP, Shah JP, Nixon IJ, et al
    Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25029.
    PubMed     Abstract available


    November 2017
  383. FULCHER CD, Haigentz M Jr, Ow TJ
    AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
    Head Neck. 2017 Nov 24. doi: 10.1002/hed.25025.
    PubMed     Abstract available


  384. ESKANDER A, Ghanem T, Agrawal A
    AHNS Series: Do you know your guidelines? Guideline recommendations for head and neck cancer of unknown primary site.
    Head Neck. 2017 Nov 21. doi: 10.1002/hed.25026.
    PubMed     Abstract available


  385. CAO C, Hu Q, Chen X
    Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25016.
    PubMed     Abstract available


  386. WONG DJY, Donaldson C, Lai LT, Coleman A, et al
    Safety and effectiveness of endovascular embolization or stent-graft reconstruction for treatment of acute carotid blowout syndrome in patients with head and neck cancer: Case series and systematic review of observational studies.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25018.
    PubMed     Abstract available


  387. LECHELT LA, Rieger JM, Cowan K, Debenham BJ, et al
    Top 10 research priorities in head and neck cancer: Results of an Alberta priority setting partnership of patients, caregivers, family members, and clinicians.
    Head Neck. 2017 Nov 17. doi: 10.1002/hed.24998.
    PubMed     Abstract available


  388. MAYS AC, Bartels HG, Wistermayer PR, Rohlfing ML, et al
    Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population.
    Head Neck. 2017 Nov 13. doi: 10.1002/hed.24992.
    PubMed     Abstract available


  389. LEONG YH, Soon YY, Lee KM, Wong LC, et al
    Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24993.
    PubMed     Abstract available


  390. DAVIDI ES, Dreifuss T, Motiei M, Shai E, et al
    Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24935.
    PubMed     Abstract available


  391. KAMSTRA JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU, et al
    Exercise therapy for trismus secondary to head and neck cancer: A systematic review.
    Head Neck. 2017;39:2352-2362.
    PubMed     Abstract available


    October 2017
  392. CHAN JYW, Wong STS, Wei WI
    Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.
    Head Neck. 2017 Oct 30. doi: 10.1002/hed.24976.
    PubMed     Abstract available


  393. TAMAKI A, Miles BA, Lango M, Kowalski L, et al
    AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24862.
    PubMed     Abstract available


  394. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24986.
    PubMed     Abstract available


  395. PENG S, Wu C, Sun W, Liu D, et al
    Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell.
    Head Neck. 2017 Oct 12. doi: 10.1002/hed.24982.
    PubMed     Abstract available


  396. HUANG WB, Wong STS, Chan JYW
    Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2017 Oct 9. doi: 10.1002/hed.24973.
    PubMed     Abstract available


  397. LIU JC
    Head and Neck Cancer, Multimodality Management, 2nd ed, Editor: Jacques Bernier Jeffrey C. Liu Springer, Switzerland, 2016, USD $329, 878 pages.
    Head Neck. 2017 Oct 5. doi: 10.1002/hed.24920.
    PubMed    


    September 2017
  398. FAN CY, Chao HL, Lin CS, Huang WY, et al
    Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24961.
    PubMed     Abstract available


  399. LECHIEN JR, Nassri A, Kindt N, Brown DN, et al
    Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24939.
    PubMed     Abstract available


  400. ONG HS, Gokavarapu S, Al-Qamachi L, Yin MY, et al
    Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24914.
    PubMed     Abstract available


  401. BURNS CL, Kularatna S, Ward EC, Hill AJ, et al
    Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24916.
    PubMed     Abstract available


  402. LOMBARDI D, Paderno A, Giordano D, Barbieri D, et al
    Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24936.
    PubMed     Abstract available


  403. AVILES-JURADO FX, Flores JC, Guma J, Ceperuelo-Mallafre V, et al
    Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24919.
    PubMed     Abstract available


  404. QIU J, Lv B, Fu M, Wang X, et al
    18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24925.
    PubMed     Abstract available


  405. LIU H, Zhang Y, Zhang T, Li F, et al
    Correlation between the pathology and clinical presentations in patients with adenoid cystic carcinoma of the external auditory canal.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24915.
    PubMed     Abstract available


  406. KAWAKITA D, Lee YA, Li Q, Chen Y, et al
    Impact of oral hygiene on head and neck cancer risk in a Chinese population.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24929.
    PubMed     Abstract available


  407. LUCIONI M, D'Ascanio L, De Nardi E, Lionello M, et al
    Management of paratracheal lymph nodes in laryngeal cancer with subglottic involvement.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24905.
    PubMed     Abstract available


  408. CHENG SJ, Chang CF, Ko HH, Lee JJ, et al
    Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24958.
    PubMed     Abstract available


  409. ITO M, Kodaira T, Tachibana H, Tomita N, et al
    Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24909.
    PubMed     Abstract available


  410. ZHANG H, Kim S, Chen Z, Nannapaneni S, et al
    Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24911.
    PubMed     Abstract available


  411. DA FONSECA FL, Yamanaka PK, Mazoti L, Arakawa-Sugueno L, et al
    Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24895.
    PubMed     Abstract available


    May 2017
  412. ZHANG D, Li F, Wu CW, Liu X, et al
    Percutaneous probe stimulation for intraoperative neuromonitoring in total endoscopic thyroidectomy: A preliminary experience.
    Head Neck. 2017;39:1001-1007.
    PubMed     Abstract available


  413. LOPEZ F, Triantafyllou A, Snyderman CH, Hunt JL, et al
    Nasal juvenile angiofibroma: Current perspectives with emphasis on management.
    Head Neck. 2017;39:1033-1045.
    PubMed     Abstract available


  414. WELLER MA, Ward MC, Berriochoa C, Reddy CA, et al
    Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2017;39:940-946.
    PubMed     Abstract available


  415. MORISOD B, Venara-Vulpe II, Alzuphar S, Monnier Y, et al
    Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
    Head Neck. 2017;39:965-973.
    PubMed     Abstract available


  416. LANSAAT L, van den Boer C, Muller SH, van der Noort V, et al
    Ex vivo humidifying capacity and patient acceptability of stoma cloths in laryngectomized individuals.
    Head Neck. 2017;39:921-931.
    PubMed     Abstract available


    April 2017
  417. GARCIA-OLMO DC, Contreras JD, Picazo MG, Lopez-Torres J, et al
    Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
    Head Neck. 2017;39:647-655.
    PubMed     Abstract available


  418. VAN LOON Y, Stiggelbout AM, Hakkesteegt MM, Langeveld TP, et al
    Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma.
    Head Neck. 2017;39:779-785.
    PubMed     Abstract available


  419. DUEK I, Amit M, Sviri GE, Gil Z, et al
    Combined endoscopic transcervical-transoral robotic approach for resection of parapharyngeal space tumors.
    Head Neck. 2017;39:786-790.
    PubMed     Abstract available


  420. ZHOU L, Luo W
    Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.
    Head Neck. 2017;39:656-661.
    PubMed     Abstract available


  421. TURRI-ZANONI M, Salzano G, Lambertoni A, Giovannardi M, et al
    Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Head Neck. 2017;39:730-736.
    PubMed     Abstract available


  422. ALMADORI G, Lauriola L, Coli A, Bussu F, et al
    Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
    Head Neck. 2017;39:684-693.
    PubMed     Abstract available


  423. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Lepera D, et al
    Transnasal endoscopic partial maxillectomy: Operative nuances and proposal for a comprehensive classification system based on 1378 cases.
    Head Neck. 2017;39:754-766.
    PubMed     Abstract available


    March 2017
  424. SIDDIQUI F, Smith RV, Yom SS, Beitler JJ, et al
    ACR appropriateness criteria((R)) nasal cavity and paranasal sinus cancers.
    Head Neck. 2017;39:407-418.
    PubMed     Abstract available


  425. IWAKI S, Maeda T, Saito M, Otsuki N, et al
    Role of immediate recurrent laryngeal nerve reconstruction in surgery for thyroid cancers with fixed vocal cords.
    Head Neck. 2017;39:427-431.
    PubMed     Abstract available


  426. NISHIO N, Fujii M, Hayashi Y, Hiramatsu M, et al
    Preoperative surgical simulation and validation of the line of resection in anterolateral craniofacial resection of advanced sinonasal sinus carcinoma.
    Head Neck. 2017;39:512-519.
    PubMed     Abstract available


  427. LOMBARDI D, Mattavelli D, Redaelli De Zinis LO, Accorona R, et al
    Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease.
    Head Neck. 2017;39:E45-E50.
    PubMed     Abstract available


  428. SIVARS L, Landin D, Haeggblom L, Tertipis N, et al
    Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Head Neck. 2017;39:419-426.
    PubMed     Abstract available


  429. MATTHEIS S, Hasskamp P, Holtmann L, Schafer C, et al
    Flex Robotic System in transoral robotic surgery: The first 40 patients.
    Head Neck. 2017;39:471-475.
    PubMed     Abstract available


  430. YU Y, Mabray M, Silveira W, Shen PY, et al
    Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Head Neck. 2017;39:432-438.
    PubMed     Abstract available


    February 2017
  431. GOOI Z, Richmon J, Agrawal N, Blair E, et al
    AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.
    Head Neck. 2017;39:201-205.
    PubMed     Abstract available


  432. FRISCH T
    Versatility of the facial artery myomucosal island flap in neopharyngeal reconstruction.
    Head Neck. 2017;39:E29-E33.
    PubMed     Abstract available


  433. MCDOWELL LJ, Jacobson MC, Levin W
    High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
    Head Neck. 2017;39:E23-E28.
    PubMed     Abstract available


  434. MEHTA V, Flores JM, Thompson RW, Nathan CA, et al
    Primary payer status, individual patient characteristics, and hospital-level factors affecting length of stay and total cost of hospitalization in total laryngectomy.
    Head Neck. 2017;39:311-319.
    PubMed     Abstract available


  435. GAVRIEL H, Eviatar E, Abu Eta R
    Hyperbaric oxygen therapy for maxillary bone radiation-induced injury: A 15-year single-center experience.
    Head Neck. 2017;39:275-278.
    PubMed     Abstract available


  436. WEAVER AN, Cooper TS, Wei S, Carroll WR, et al
    DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery.
    Head Neck. 2017;39:206-214.
    PubMed     Abstract available


    January 2017
  437. HOFSTEDE TM, Jacob RF, Montgomery P, Wesley P, et al
    Surgical preparation of nasal defects to enhance the implant-retained facial prostheses: A case report.
    Head Neck. 2017;39:E4-E11.
    PubMed     Abstract available


  438. ALLENSWORTH JJ, O'Dell KD, Schindler JS
    Bilateral vocal fold paralysis and dysphagia secondary to diffuse idiopathic skeletal hyperostosis.
    Head Neck. 2017;39:E1-E3.
    PubMed     Abstract available


  439. BEECH NM, Porceddu S, Batstone MD
    Radiotherapy-associated dental extractions and osteoradionecrosis.
    Head Neck. 2017;39:128-132.
    PubMed     Abstract available


  440. ANSARIN M, Cattaneo A, De Benedetto L, Zorzi S, et al
    Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery.
    Head Neck. 2017;39:71-81.
    PubMed     Abstract available


  441. RACKLEY TP, Namelo WC, Palaniappan N, Cole N, et al
    Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil.
    Head Neck. 2017;39:17-23.
    PubMed     Abstract available


  442. BAUMEISTER P, Rauch J, Jacobi C, Kisser U, et al
    Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
    Head Neck. 2017;39:7-16.
    PubMed     Abstract available


    April 2016
  443. SABA NF, Salama JK, Beitler JJ, Busse PM, et al
    ACR Appropriateness criteria(R) for nasopharyngeal carcinoma.
    Head Neck. 2016 Apr 30. doi: 10.1002/hed.24423.
    PubMed     Abstract available


  444. ROSKO AJ, Spector ME, Griffin GR, Vainshtein JM, et al
    Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer.
    Head Neck. 2016 Apr 15. doi: 10.1002/hed.24348.
    PubMed     Abstract available


  445. OMURA G, Ando M, Saito Y, Kobayashi K, et al
    Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer.
    Head Neck. 2016 Apr 9. doi: 10.1002/hed.24176.
    PubMed     Abstract available


  446. CHOI YS, Park SG, Song EK, Cho SH, et al
    Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Head Neck. 2016 Apr 4. doi: 10.1002/hed.24438.
    PubMed     Abstract available


    March 2016
  447. HARRIS BN, Bhuskute AA, Rao S, Farwell DG, et al
    Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Head Neck. 2016 Mar 25. doi: 10.1002/hed.24443.
    PubMed     Abstract available


  448. PERETTI G, Piazza C, Penco S, Santori G, et al
    Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
    Head Neck. 2016 Mar 11. doi: 10.1002/hed.24424.
    PubMed     Abstract available


    February 2016
  449. EDSON MA, Garden AS, Takiar V, Glisson BS, et al
    Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy.
    Head Neck. 2016 Feb 27. doi: 10.1002/hed.24387.
    PubMed     Abstract available


  450. XIONG J, Krishnaswamy G, Raynor S, Loh KS, et al
    Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.
    Head Neck. 2016 Feb 18. doi: 10.1002/hed.24296.
    PubMed     Abstract available


  451. VENGALIL S, Giuliani ME, Huang SH, McNiven A, et al
    Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.
    Head Neck. 2016 Feb 1. doi: 10.1002/hed.24374.
    PubMed     Abstract available


    December 2015
  452. LEWIS GD, Holliday EB, Kocak-Uzel E, Hernandez M, et al
    Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes.
    Head Neck. 2015 Dec 26. doi: 10.1002/hed.24341.
    PubMed     Abstract available


  453. FLORIE M, Baijens L, Kremer B, Kross K, et al
    Relationship between swallow-specific quality of life and fiber-optic endoscopic evaluation of swallowing findings in patients with head and neck cancer.
    Head Neck. 2015 Dec 23. doi: 10.1002/hed.24333.
    PubMed     Abstract available


  454. OUYOUNG LM, Swanson MS, Villegas BC, Damodar D, et al
    ABCLOVE: Voice therapy outcomes for patients with head and neck cancer.
    Head Neck. 2015 Dec 22. doi: 10.1002/hed.24322.
    PubMed     Abstract available


  455. SENGAR M, Chorghe S, Jadhav K, Singh S, et al
    Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: Plasma versus urine.
    Head Neck. 2015 Dec 15. doi: 10.1002/hed.24297.
    PubMed     Abstract available


    November 2015
  456. DRIESSEN CM, Uijen MJ, van der Graaf WT, van Opstal CC, et al
    Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer.
    Head Neck. 2015 Nov 28. doi: 10.1002/hed.24281.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: